FBXO7 and hepatocellular carcinoma: Downregulation of FBXO7 in HCC elevates PRMT1 protein level, thereby inducing PHGDH methylation and activation, potentiating serine synthesis, ameliorating oxidative stress, and promoting HCC cell growth.